KARE Biosciences
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia (NCT05706454) | KARE Biosciences | 2022-11-10 |
Track KARE Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.